The ACSR is committed to supporting the next generation of HIV researchers by offering a grant award program for early-stage investigators interested in conducting HIV-related research, especially for malignancies. The goal is to encourage novel and rigorous scientific research projects that utilize biospecimens and data in the ACSR inventory via a small grant funding mechanism and contribute toward greater understanding of HIV disease, biology, improved treatment, and discovery of a cure. See below to learn more about our Young Investigator Pilot Award opportunities as well as our past and current awardees. Click here to register for email updates about this and other HIV funding opportunities.
ACSR Funding Opportunities
MEET OUR YOUNG INVESTIGATOR PILOT AWARD AWARDEES!
- ACSR YOUNG INVESTIGATOR PILOT AWARD: FALL LOI CYCLE IS CLOSED! Please contact us for more information on upcoming cycles.
Other Funding Opportunities
Funding opportunities from non-ACSR sources.
- AIDS Malignancy Consortium: Closed to applications.
- National Institutes of Health (NIH) Funding Opportunity Announcements
- RFA-RM-22-022, Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed), Earliest Submission Date: August 29, 2022. Expiration Date: September 29, 2022
- The HU CFAR Monkeypox Rapid Response Grant Program seeks to support and catalyze rapid response research at Harvard University and its affiliated institutions focused on the emerging monkeypox
epidemic, in the context of HIV. The Monkeypox Rapid Response RFP has a rolling deadline, and applications will be administratively reviewed as they are received. See the fill announcement here: https://files.constantcontact.com/c70eae87001/45ffa64b-67a7-4351-9d76-7ce612f84593.pdf?rdr=true - NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional): The NCI, in alignment with NIH, continues to demonstrate a strong commitment to attracting, training, and retaining the best minds from diverse backgrounds to ensure long-term successes in the cancer research enterprise. The Cancer Moonshot Scholar Diversity Program (CMSDP) was developed to inspire and support the next generation of world-class and diverse scientists and health innovators focused on breakthroughs that will make a difference for patients and drive progress toward the goal of ending cancer as we know it today. Application Due Date: November 8, 2022
- CFAR Adelante is now accepting applications for the fifth cohort of projects: https://cfar-adelante.org/apply-for-program/how-to-apply Concept proposals are due Thursday, November 10, 2022 (5:00 p.m. EST)